Peter Kappel | Interim CEO and Chairman |
Jade Cheng | CFO |
Paul Lam | Director, IR |
Daniel Shahrabani | Fard Investments |
Good afternoon, everyone, and thank you for participating in today’s conference call to discuss Burcon NutraScience Corporation’s Fiscal 2022 Ended March 31, 2022.
Joining us today are Peter Kappel, Interim CEO and Chairman of the Board; and Jade Cheng, the Company’s Chief Financial Officer.
Following their remarks, we will open up the call for your questions. After the presentation, there will be an opportunity to ask questions. [Operator Instructions] Then before we conclude today’s call, I will provide the Company’s Safe Harbor statement with important cautions regarding the forward-looking statements made during this call.